Kristian Reich

71PUBLICATIONS
116CO-AUTHORS
Disease surveillanceAllergyMolecular targetsHumoural immunology and immunochemistryPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Nov 11, 2025
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis.

Melinda Gooderham, Mahreen Ameen, H Chih-Ho Hong

|Aug 29, 2025
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials.

Kristian Reich, Richard G Langley, Juan Francisco Silvestre Salvador

|Mar 24, 2025
Favourable response of Blaschko linear psoriasis to interleukin-23 inhibition.

Jeremias L K Reich, Alexandros Onoufriadis, John A McGrath

|Feb 15, 2025
Efficacy and safety of mirikizumab in psoriasis: a systematic review and meta-analysis of randomized controlled trials.

Mable Pereira, Ancy Jenil Franco, Karthik Chintharala

|May 20, 2024
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.

María José Valencia López, Brigitte Stephan, Anna Meineke

Pageof 12